Works by Jin-Seok Kim


Results: 287
    1
    2
    3

    Prevalence of Isolated Nocturnal Hypertension and Development of Arterial Stiffness, Left Ventricular Hypertrophy, and Silent Cerebrovascular Lesions: The KoGES (Korean Genome and Epidemiology Study).

    Published in:
    2022
    By:
    • Seong Hwan Kim;
    • Chol Shin;
    • Sunwon Kim;
    • Jin-Seok Kim;
    • Sang Yup Lim;
    • Hyeong-Seok Seo;
    • Hong Euy Lim;
    • Ki-Chul Sung;
    • Goo-Yeong Cho;
    • Seung Ku Lee;
    • Yong-Hyun Kim;
    • Kim, Seong Hwan;
    • Shin, Chol;
    • Kim, Sunwon;
    • Kim, Jin-Seok;
    • Lim, Sang Yup;
    • Seo, Hyeong-Seok;
    • Lim, Hong Euy;
    • Sung, Ki-Chul;
    • Cho, Goo-Yeong
    Publication type:
    journal article
    4

    Variation in immunoglobulin use and impact on survival in myeloma.

    Published in:
    EJHaem, 2024, v. 5, n. 4, p. 690, doi. 10.1002/jha2.938
    By:
    • Chai, Khai Li;
    • Wellard, Cameron;
    • Thao, LTP;
    • Aoki, Naomi;
    • Moore, Elizabeth M;
    • Augustson, Bradley M;
    • Bapat, Akshay;
    • Blacklock, Hilary;
    • Chng, Wee J;
    • Cooke, Rachel;
    • Forsyth, Cecily J;
    • Goh, Yeow‐Tee;
    • Hamad, Nada;
    • Harrison, Simon J;
    • Ho, P Joy;
    • Hocking, Jay;
    • Kerridge, Ian;
    • Kim, Jin Seok;
    • Kim, Kihyun;
    • King, Tracy
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22

    Intensified First Cycle of Rituximab Plus Eight Cycles of Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone with Rituximab Chemotherapy for Advanced-Stage or Bulky Diffuse Large B-Cell Lymphoma: A Multicenter Phase II Consortium for Improving Survival of Lymphoma (CISL) Study.

    Published in:
    Cancer Research & Treatment, 2023, v. 55, n. 4, p. 1355, doi. 10.4143/crt.2023.271
    By:
    • Yu Ri Kim;
    • Jin Seok Kim;
    • Won Seog Kim;
    • Hyeon Seok Eom;
    • Deok-Hwan Yang;
    • Sung Hwa Bae;
    • Hyo Jung Kim;
    • Jae Hoon Lee;
    • Suk-Joong Oh;
    • Sung-Soo Yoon;
    • Jae-Yong Kwak;
    • Chul Won Choi;
    • Min Kyoung Kim;
    • Sung Young Oh;
    • Hye Jin Kang;
    • Seung Hyun Nam;
    • Hyeok Shim;
    • Joon Seong Park;
    • Yeung-Chul Mun;
    • Cheolwon Suh
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29
    30
    31

    Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL).

    Published in:
    Journal of Hematology & Oncology, 2012, v. 5, n. 1, p. 49, doi. 10.1186/1756-8722-5-49
    By:
    • Yu Ri Kim;
    • Jin Seok Kim;
    • Yoo Hong Min;
    • Dok HyunYoon;
    • Ho-Jin Shin;
    • Yeung-Chul Mun;
    • Yong Park;
    • Young Rok Do;
    • Seong Hyun Jeong;
    • Joon Seong Park;
    • Sung Yong Oh;
    • Suee Lee;
    • Eun Kyung Park;
    • Joung-Soon Jang;
    • Won-Sik Lee;
    • Hwe-Won Lee;
    • HyeonSeok Eom;
    • Jae-sook Ahn;
    • Jae-Heon Jeong;
    • Sun Kyung Baek
    Publication type:
    Article
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43

    Clinical impact of frailty on treatment outcomes of elderly patients with relapsed and/or refractory multiple myeloma treated with lenalidomide plus dexamethasone.

    Published in:
    International Journal of Hematology, 2021, v. 113, n. 1, p. 81, doi. 10.1007/s12185-020-02988-6
    By:
    • Lee, Ho Sup;
    • Kim, Kihyun;
    • Lee, Je-Jung;
    • Yoon, Sung-Soo;
    • Bang, Soo-Mee;
    • Kim, Jin Seok;
    • Eom, Hyeon-Seok;
    • Yoon, Dok Hyun;
    • Lee, Yoojin;
    • Shin, Ho-Jin;
    • Park, Yong;
    • Jo, Jae-Cheol;
    • Lee, Won Sik;
    • Do, Young Rok;
    • Mun, Yeung-Chul;
    • Lee, Mark Hong;
    • Kim, Hyo Jung;
    • Kim, Sung-Hyun;
    • Kim, Min Kyoung;
    • Lim, Sung-Nam
    Publication type:
    Article
    44
    45
    46
    47
    48
    49

    Mitigating Drug–Target–Drug Complexes in Patients With Paroxysmal Nocturnal Hemoglobinuria Who Switch C5 Inhibitors.

    Published in:
    Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 4, p. 904, doi. 10.1002/cpt.2851
    By:
    • Nishimura, Jun‐ichi;
    • Soubret, Antoine;
    • Arase, Noriko;
    • Buatois, Simon;
    • Hotta, Masaki;
    • Charoin, Jean‐Eric;
    • Ito, Yoshikazu;
    • Sreckovic, Sasha;
    • Takamori, Hiroyuki;
    • Bucher, Christoph;
    • Ueda, Yasutaka;
    • Hernández‐Sánchez, Jules;
    • Gotanda, Keisuke;
    • Jordan, Gregor;
    • Shinomiya, Kenji;
    • Ramos, Julia;
    • Kim, Jin Seok;
    • Panse, Jens;
    • de Latour, Régis Peffault;
    • Röth, Alexander
    Publication type:
    Article
    50